Evidence map›Paper›PMID 34215258›Full record

ArticleCell communication and signaling : CCS2021

PML-II regulates ERK and AKT signal activation and IFNα-induced cell death.

Xueqiong Meng, Yixiang Chen, Salvador Macip, Keith Leppard

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. [Bioinformatics analysis and validation of the interaction between PML protein and TAB1 protein].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Xueqiong MengSchool of Basic Medicine, Henan University of Science and Technology, Luoyang, China.
Yixiang ChenSchool of Basic Medicine, Henan University of Science and Technology, Luoyang, China.
Salvador MacipMechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.
Keith LeppardSchool of Life Sciences, University of Warwick, Coventry, UK. keith.leppard@warwick.ac.uk.ORCID 0000-0003-2155-7919
Henan University of Science and Technology · CNUniversitat Oberta de Catalunya · ESUniversity of Leicester · GBUniversity of Warwick · GB

Funding

Henan University 13480048
6 · The paper itself

Abstract

backgroundThe requirement of promyelocytic leukaemia protein (PML) in interferon (IFN)-induced cell apoptosis is well-established. However, the exact mechanisms by which the multiple isoforms of PML protein participate in this process remain not well-understood. We previously demonstrated that PML isoform II (PML-II) positively regulates induced gene expression during a type I IFN response and evaluate here how PML-II contributes to IFNα-induced cell death.

methodsHeLa cells were transiently depleted of PML-II by siRNA treatment and the response of these cells to treatment with IFNα assessed by molecular assays of mRNA and proteins associated with IFN and apoptosis responses.

resultsIn HeLa cells, death during IFNα stimulation was reduced by prior PML-II depletion. PML-II removal also considerably decreased the induced expression of pro-apoptotic ISGs such as ISG54 (IFIT2), and substantially impaired or prevented expression of PUMA and TRAIL, proteins that are associated with the intrinsic and extrinsic apoptotic pathways respectively. Thirdly, PML-II depletion enhanced ERK and AKT pro-survival signaling activation suggesting that PML-II normally suppresses signaling via these pathways, and that lack of PML-II hence led to greater than normal activation of AKT signaling upon IFNα stimulation and consequently increased resistance to IFNα-induced apoptosis.

conclusionsThe positive contribution of PML-II to the expression of various IFNα-induced pro-apoptotic proteins and its inhibition of pro-survival signaling together provide a mechanistic explanation for reduced apoptosis under conditions of PML deficiency and may account for at least part of the role of PML as a tumor suppressor gene. Video Abstract.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCell SurvivalGene Expression RegulationHeLa CellsHumansInterferon-alphaMAP Kinase Signaling SystemNeoplasmsPromyelocytic Leukemia ProteinProtein IsoformsProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRNA-Binding ProteinsRNA, Small InterferingTNF-Related Apoptosis-Inducing LigandApoptosis Regulatory ProteinsBBC3 protein, humanIFIT2 protein, humanIFNA1 protein, humanInterferon-alphaPML protein, humanPromyelocytic Leukemia ProteinProtein IsoformsProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRNA-Binding ProteinsRNA, Small InterferingTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanAKTApoptotic signalingERKIFNαPML-IIPromyelocytic leukemia protein

Identifiers

PMID34215258
PMCPMC8252201
OpenAlexW3175157451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.